SARS-CoV-2 synthetic genome
A safe and accurate research and development path
Our complete synthetic reference material is a full-length synthetic genome for SARS-CoV-2, ensuring a safe, accurate path to vaccine, therapeutic, and diagnostic research and development.
Full-length genomes
Telesis Bio offers multiple SARS-CoV-2 full-length genome tools for research. Contact us for ordering or more information.
Synthetic genome
SARS-CoV-2 complete synthetic reference material | Contact us
Synthetic genome with T7 promoter
SARS-CoV-2 genome with T7 promoter and poly(A) tail | Contact us
Synthetic genome D614G
SARS-CoV-2 genome-encoding spike protein variant D614G, including a T7 promoter and poly(A) tail | Contact us
Custom synthetic genome
Our team of experienced scientists can work with you to design and engineer custom SARS-CoV-2 genomes | Contact us
Replicons
Telesis Bio offers multiple SARS-CoV-2 full-length genome tools for research. Contact us for ordering or more information.
Synthetic replicon with RLuc reporter and neomycin marker
SARS-CoV-2 replicon-encoding Renilla luciferase reporter and neomycin genes, with deletions of S, E, M and ORFs 6, 7a, 7b, 10 genes; in vitro transcription-compatible | Contact us
Contact us
For ordering or more information, select the products that interest you. A representative will contact you shortly.
Telesis Bio is committed to best practices in biosecurity and is a member of the International Gene Synthesis Consortium. We support researchers and the synthetic biology community with the responsible synthesis of genes for discovering and creating new medicines, diagnostic tests, agricultural biotechnology products, industrial chemicals, and other beneficial applications.